| SpectraBase Spectrum ID |
B2qCiKySRLU |
| Name |
LSZ Isomer II |
| Classification |
Hallucinogenic ergoline designer drug |
| Copyright |
Copyright © 2024-2025 DigiLab GmbH and Wiley-VCH GmbH. All Rights Reserved. |
| Exact Mass |
335.199762436 u |
| Formula |
C21H25N3O |
| InChI |
InChI=1S/C21H25N3O/c1-12-7-13(2)24(12)21(25)15-8-17-16-5-4-6-18-20(16)14(10-22-18)9-19(17)23(3)11-15/h4-6,8,10,12-13,15,19,22H,7,9,11H2,1-3H3 |
| InChIKey |
DUKNIHFTDAXJON-UHFFFAOYSA-N |
| Ionization Type |
Electron Ionization (EI) |
| Molecular Weight |
335.451 g/mol |
| Nominal Mass |
335 u |
| Quality |
968 |
| Retention Index |
3235 |
| SMILES |
C12C(C3=C4C(C2)=CNC4=CC=C3)=CC(C(N2C(CC2C)C)=O)CN1C |
| SPLASH |
splash10-00di-1891000000-7da5edbe8e56b8a97ce5 |
| Sample Comments |
Stereo configuration unknown |
| Source of Spectrum |
DigiLab GmbH (C) 2024 |
| Synonyms |
L-1 isomer II
Lysergic acid 2,4-dimethylazetidide isomer II
(8-beta)-8-([(2S,4S)-2,4-Dimethylazetidin-1-yl]carbonyl)-6-methyl-9,10-didehydroergoline |
| Technique |
GC/MS |
| Wiley ID |
DD2024_020099 |
